HealthRX.com · Printable supplement log
GHK-Cu coadministration record for a pharmacist or clinician
Record the GHK-Cu product and route, every zinc, copper or iron product with its elemental amount, and the medical context. That is what a pharmacist needs to judge a real mineral problem, instead of following an invented timing rule.
The GHK-Cu product
Exact name, brand or pharmacy
Lot number and stated concentration
Other listed ingredients
Routeintact-skin topical, after a procedure, microneedled, or injected
What you use it forcosmetic, wound care, other
Mineral products and medicines
"Zinc" is not a dose. Copy the elemental amount from the label, including multivitamins and denture creams that contain zinc.
| Product | Mineral or medicine | Elemental amount per dose (mg) | How often | Taking since |
|---|---|---|---|---|
Medical context to mention
- Wilson disease, or a copper-lowering medicine such as penicillamine or trientine
- Liver disease
- Kidney disease
- Pregnancy or breastfeeding
- Cancer treatment
- A past low copper or low blood count result
What the evidence says
- A systematic review of 37 published cases of zinc-induced blood problems found low serum copper in every patient; most recovered after stopping zinc and taking copper.[1]
- In laboratory tests almost no GHK-Cu or copper crossed intact human skin over 9 hours.[2]
- FDA flags injectable compounded GHK-Cu for possible immune reactions caused by aggregation and peptide-related impurities.[3]
- A systematic review searched to March 2026 found 20 GHK-Cu aesthetic studies, 18 preclinical and 2 randomized trials, all testing GHK-Cu on its own rather than with a food or supplement.[4]
- The registered topical GHK-Cu trial, NCT07437586, has posted no results.[5]
Questions for the pharmacist
- Is my total zinc intake from all products high enough to affect my copper?
- Should my copper level or blood count be checked?
- Does my route of GHK-Cu (on skin, after a procedure, or injected) change anything about my supplements?
- Do any of my medicines change copper or zinc balance?
- If I use an injected product, who verified its identity and sterility?
Sources for the facts on this sheet
- Dutta A, Chaudhary V, Kumari S, et al. Zinc-Induced Hematologic Toxicities: A Systematic Review of Descriptive Studies. Biol Trace Elem Res 2026. PMID 42087025. https://pubmed.ncbi.nlm.nih.gov/42087025/
- Li H, Low YS, Chong HP, et al. Microneedle-Mediated Delivery of Copper Peptide Through Skin. Pharm Res 2015. PMID 25690343. https://pubmed.ncbi.nlm.nih.gov/25690343/
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Accessed 2026-10-18. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- Mokhtar J, Mohamad B, Haddad J, et al. The Regenerative Potential of GHK-Cu in Aesthetic Medicine. Aesthet Surg J 2026. PMID 42619529. https://pubmed.ncbi.nlm.nih.gov/42619529/
- U.S. National Library of Medicine, ClinicalTrials.gov (API v2 record). NCT07437586: A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Split-Wound Study of Topical GHK-Cu (Copper(II)-Peptide Complex) Gel to Accelerate Re-Epithelialization of Standardized Acute Skin Wounds in Healthy Adults. Accessed 2026-10-18. https://clinicaltrials.gov/api/v2/studies/NCT07437586
This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.